| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 40.783 | 43.107 | 48.150 | 75.131 | 97.530 | 85.012 | 90.565 | 96.077 | 100.107 | 111.540 |
| Total Income - EUR | 40.787 | 43.187 | 48.150 | 75.429 | 98.006 | 85.216 | 96.125 | 100.133 | 100.108 | 111.541 |
| Total Expenses - EUR | 37.786 | 45.391 | 50.155 | 74.636 | 93.520 | 73.028 | 69.300 | 94.326 | 88.279 | 116.996 |
| Gross Profit/Loss - EUR | 3.001 | -2.204 | -2.005 | 793 | 4.486 | 12.188 | 26.824 | 5.808 | 11.829 | -5.455 |
| Net Profit/Loss - EUR | 1.777 | -2.636 | -2.487 | 39 | 3.506 | 11.356 | 25.979 | 4.974 | 10.848 | -8.500 |
| Employees | 3 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 4 | 4 |
Check the financial reports for the company - Bratosin Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.134 | 10.748 | 7.378 | 4.113 | 1.130 | 22.907 | 52.198 | 28.306 | 18.643 | 7.937 |
| Current Assets | 15.073 | 13.871 | 14.375 | 17.398 | 24.317 | 31.078 | 42.587 | 45.740 | 31.514 | 8.451 |
| Inventories | 0 | 0 | 0 | 0 | 1.517 | 0 | 0 | 616 | 0 | 0 |
| Receivables | 13.962 | 10.983 | 11.845 | 11.493 | 16.726 | 25.650 | 30.282 | 44.256 | 24.608 | 0 |
| Cash | 1.112 | 2.888 | 2.531 | 5.905 | 6.074 | 5.428 | 12.306 | 868 | 6.906 | 8.451 |
| Shareholders Funds | 26.063 | 23.161 | 20.283 | 19.949 | 23.069 | 33.987 | 53.875 | 49.857 | 29.615 | 12.908 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.145 | 1.457 | 1.470 | 2.314 | 2.379 | 19.998 | 40.909 | 24.188 | 20.542 | 3.480 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Bratosin Med S.r.l.